Antigen-specific humoral immune responses by CRISPR/Cas9-edited B cells
H. Hartweger, A. T. McGuire, M. Horning, J. J. Taylor, P. Dosenovic, D. Yost, A. Gazumyan, M. S. Seaman, L. Stamatatos, M. Jankovic, M. C. Nussenzweig
CRISPR/Cas9-edited B cells produce broadly neutralizing antibodies against HIV-1 and elicit protective immune responses in vivo.
bioRxiv · Jan 26, 2019Immunology